5 drug suppliers to face punishment for false reporting of transaction

Published: 2010-01-12 07:00:00

Updated: 2010-01-12 07:00:00

The Health Insurance Review and Assessment Service (HIRAS) announced on January 8 that it has discovered 5 drug suppliers who had made falsified reporting of drug dealings as a result of its inspection and will mete our due administrative dispositions including suspension of business.

Of the t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK